Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bronchodilatation and anticholinergic agents].

J M Tschopp1

  • 1Centre valaisan de pneumologie, Montana.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|May 29, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Sleep fragmentation and sleep-disordered breathing in individuals living close to main roads: results from a population-based study.

Sleep medicine·2014
Same author

Acute respiratory health effects of urban air pollutants in adults with different patterns of underlying respiratory disease.

Swiss medical weekly·2012
Same author

[Cystic fibrosis and the practitioner: a paradigm for modern medicine].

Revue medicale suisse·2011
Same author

The centenary of medical thoracoscopy.

The European respiratory journal·2010
Same author

[If physicians would look past the end of their nose...].

Revue medicale suisse·2009

Ipratropium, an anticholinergic bronchodilator, effectively treats chronic bronchitis and emphysema. It complements other respiratory medications, enhancing bronchodilation duration and level, particularly when combined with beta-agonists or theophylline.

Area of Science:

  • Pharmacology
  • Respiratory Medicine

Context:

  • Anticholinergic compounds are effective bronchodilators.
  • Ipratropium, a congener of atropine, is a muscarinic receptor antagonist with fewer side effects.
  • It plays a complementary role alongside beta-agonists and theophylline.

Purpose:

  • To evaluate the role and efficacy of ipratropium as a bronchodilator.
  • To compare its potency with other bronchodilators in different respiratory conditions.

Summary:

  • Ipratropium is a potent bronchodilator, especially in chronic bronchitis and emphysema.
  • In stable asthma, it may be less potent than beta-adrenergic agents.
  • Its combination with other bronchodilators significantly enhances bronchodilation in terms of level and duration.

Related Experiment Videos

Impact:

  • Ipratropium offers a valuable therapeutic option for managing obstructive airway diseases.
  • Its complementary action expands treatment possibilities for patients with asthma and COPD.
  • Understanding its role in combination therapy can optimize patient outcomes.